Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE

Hoyles RK, Khan K, Shiwen X, Howat SL, Lindahl GE, Leoni P, du Bois RM, Wells AU, Black CM, Abraham DJ, Denton CP. Fibroblast-specific perturbation of transforming growth factor beta signaling provides insight into potential pathogenic mechanisms of scleroderma-associated lung fibrosis - exaggerated response to alveolar epithelial injury in a novel mouse model. Arthritis Rheum. 2008;58:1175–88.

Article  CAS  PubMed  Google Scholar 

Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819.

Article  PubMed  PubMed Central  Google Scholar 

Dhooria S, Sehgal IS, Agarwal R, Muthu V, Prasad KT, Kathirvel S, Garg M, Bal A, Aggarwal AN, Behera D. Incidence, prevalence, and national burden of interstitial lung diseases in India: estimates from two studies of 3089 subjects. PLoS ONE. 2022;17:e0271665.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jimenez D et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54.

Galanaud JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome. Thromb Res. 2018;164:100–9.

Article  CAS  PubMed  Google Scholar 

Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar TL, Konstantinides SV, McCumber M, et al. Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost. 2014;40:724–35.

Article  PubMed  Google Scholar 

Sogaard KK, Schmidt M, Pedersen L, Horvath-Puho E, Sorensen HT. 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation. 2014;130:829–36.

Article  PubMed  Google Scholar 

Law Y, Chan YC, Cheng SWK. Epidemiological updates of venous thromboembolism in a Chinese population. Asian J Surg. 2018;41:176–82.

Article  PubMed  Google Scholar 

Zhang Z, Lei J, Shao X, Dong F, Wang J, Wang D, Wu S, Xie W, Wan J, Chen H, et al. Trends in hospitalization and In-Hospital mortality from VTE, 2007 to 2016, in China. Chest. 2019;155:342–53.

Article  PubMed  Google Scholar 

Hyldgaard C, Bendstrup E, Pedersen AB, Pedersen L, Ellingsen T. Interstitial lung disease in connective tissue diseases: survival patterns in a Population-based cohort. J Clin Med 2021; 10.

Luo Q, Xie J, Han Q, Tang C, Chen X, Wu L, Chen R. Prevalence of venous thromboembolic events and diagnostic performance of the wells score and revised geneva scores for pulmonary embolism in patients with interstitial lung disease: a prospective study. Heart Lung Circ. 2014;23:778–85.

Article  PubMed  Google Scholar 

Sun H, Liu M, Yang X, Xi L, Xu W, Deng M, Ren Y, Xie W, Dai H, Wang C. Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization. Thromb J. 2023;21:17.

Article  PubMed  PubMed Central  Google Scholar 

Riva N, Donadini MP, Ageno W. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation. Thromb Haemost. 2015;113:1176–83.

Article  PubMed  Google Scholar 

Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011;9:1.

Article  PubMed  PubMed Central  Google Scholar 

Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Thromb Res. 2015;135:50–7.

Article  CAS  PubMed  Google Scholar 

Molander V, Bower H, Frisell T, Askling J. Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Ann Rheum Dis. 2021;80:169–75.

Article  CAS  PubMed  Google Scholar 

Guibert F, Garnier AS, Wacrenier S, Piccoli G, Djema A, Gansey R, Demiselle J, Brilland B, Cousin M, Besson V et al. Patients with ANCA-Associated Glomerulonephritis and connective tissue diseases: a comparative study from the Maine-Anjou AAV Registry. J Clin Med 2019; 8.

Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie. 2010;30:5–.

Article  CAS  PubMed  Google Scholar 

Saghazadeh A, Hafizi S, Rezaei N. Inflammation in venous thromboembolism: cause or consequence? Int Immunopharmacol. 2015;28:655–65.

Article  CAS  PubMed  Google Scholar 

Wang Y, Golden JB, Fritz Y, Zhang X, Diaconu D, Camhi MI, Gao H, Dawes SM, Xing X, Ganesh SK, et al. Interleukin 6 regulates psoriasiform inflammation-associated thrombosis. JCI Insight. 2016;1:e89384.

Article  PubMed  PubMed Central  Google Scholar 

Grimnes G, Isaksen T, Tichelaar Y, Brox J, Braekkan SK, Hansen JB. C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study. Haematologica. 2018;103:1245–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012;379:244–9.

Article  PubMed  Google Scholar 

Habe K, Wada H, Higashiyama A, Akeda T, Tsuda K, Mori R, Kakeda M, Matsumoto T, Ohishi K, Yamanaka K, et al. The plasma levels of ADAMTS-13, Von Willebrand Factor, VWFpp, and fibrin-related markers in patients with systemic sclerosis having thrombosis. Clin Appl Thromb Hemost. 2018;24:920–7.

Article  CAS  PubMed  Google Scholar 

Habe K, Wada H, Higashiyama A, Akeda T, Tsuda K, Mori R, Kakeda M, Yamanaka K, Mizutani H. Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations. Sci Rep. 2019;9:1410.

Article  PubMed  PubMed Central  Google Scholar 

Sener S, Basaran O, Lacinel Gurlevik S, Kaya Akca U, Atalay E, Kasap Cuceoglu M, Balik Z, Batu ED, Bilginer Y, Ozsurekci Y, Ozen S. Challenges in diagnosing COVID-19 related disease in pediatric patients with rheumatic disease. Mod Rheumatol. 2022;32:1108–13.

Article  PubMed  Google Scholar 

Wang F, Liu J, Fang Y, Wen J, He M, Han Q, Li X. Hypercoagulability in rheumatoid arthritis: a bibliometric analysis and Retrospective Data Mining Study. ACS Omega. 2023;8:48522–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habe K, Wada H, Mizutani K, Matsushima Y, Kondo M, Yamanaka K. The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease. Clin Rheumatol. 2021;40:4675–83.

Article  PubMed  Google Scholar 

Qiang F, Xu H, Sheng J. Relationship between plasma fibrinogen degradation products(FDP) and D-dimer levels and disease activity in rheumatoid arthritis: a STROBE compliant article. Med (Baltim). 2022;101:e30455.

Article  CAS  Google Scholar 

Xue L, Tao L, Li X, Wang Y, Wang B, Zhang Y, Gao N, Dong Y, Xu N, Xiong C, et al. Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis. Sci Rep. 2021;11:16903.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martis N, Jamme M, Bagnis-Isnard C, Pouteil-Noble C, Presne C, Vigneau C, Grange S, Burtey S, Coindre JP, Wynckel A, et al. Systemic autoimmune disorders associated with thrombotic microangiopathy: a cross-sectional analysis from the French National TMA registry: systemic autoimmune disease-associated TMA. Eur J Intern Med. 2021;93:78–86.

Article  CAS  PubMed  Google Scholar 

Murdaca G, Colombo BM, Cagnati P, Gulli R, Spano F, Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis. 2012;224:309–17.

Article  CAS  PubMed  Google Scholar 

Setiadi H, Yago T, Liu Z, McEver RP. Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin-dependent inflammation and thrombosis. Blood Adv. 2019;3:168–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bugala K, Mazurek A, Gryga K, Komar M, Kopec G, Musial J, Podolec P, Perricone C, Plazak W. Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients. Clin Rheumatol. 2018;37:2087–93.

Article  PubMed  Google Scholar 

Meng Y, Yin Q, Ma Q, Qin H, Zhang J, Zhang B, Pang H, Tian H. FXII regulates the formation of deep vein thrombosis via the PI3K/AKT signaling pathway in mice. Int J Mol Med 2021; 47.

Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109:2698–704.

Article  PubMed  Google Scholar 

Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13:34–45.

Article  CAS  PubMed  Google Scholar 

Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr. 2018;6:142.

Article  PubMed  PubMed Central  Google Scholar 

Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circul Res. 2018;122:337–51.

Article  CAS  Google Scholar 

Bowie EJ, Solberg LA Jr., Fass DN, Johnson CM, Knutson GJ, Stewart ML, Zoecklein LJ. Transplantation of normal bone marrow into a pig with severe Von Willebrand’s disease. J Clin Invest. 1986;78:26–30.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif